Top

Quality of Life Research

Gepubliceerd in:

27-07-2022

Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS® sleep and pain short forms

Auteurs: Manshu Yang, San Keller, Jin-Mann S. Lin

Gepubliceerd in: Quality of Life Research | Uitgave 12/2022

Abstract

Purpose

To evaluate the psychometric properties of the patient-reported outcome measurement information system® (PROMIS) short forms for assessing sleep disturbance, sleep-related impairment, pain interference, and pain behavior, among adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Methods

Data came from the Multi-Site ME/CFS study conducted between 2012 and 2020 at seven ME/CFS specialty clinics across the USA. Baseline and follow-up data from ME/CFS and healthy control (HC) groups were used to examine ceiling/floor effects, internal consistency reliability, differential item functioning (DIF), known-groups validity, and responsiveness.

Results

A total of 945 participants completed the baseline assessment (602 ME/CFS and 338 HC) and 441 ME/CFS also completed the follow-up. The baseline mean T-scores of PROMIS sleep and pain measures ranged from 57.68 to 62.40, about one standard deviation above the national norm (T-score = 50). All four measures showed high internal consistency (ω = 0.92 to 0.97) and no substantial floor/ceiling effects. No DIF was detected by age or sex. Known-groups comparisons among ME/CFS groups with low, medium, and high functional impairment showed significant small-sized differences in scores (η² = 0.01 to 0.05) for the two sleep measures and small-to-medium-sized differences (η² = 0.01 to 0.15) for the two pain measures. ME/CFS participants had significantly worse scores than HC (η² = 0.35 to 0.45) for all four measures. Given the non-interventional nature of the study, responsiveness was evaluated as sensitivity to change over time and the pain interference measure showed an acceptable sensitivity.

Conclusion

The PROMIS sleep and pain measures demonstrated satisfactory psychometric properties supporting their use in ME/CFS research and clinical practice.

vorige artikel Mapping PROMIS physical function and pain interference to the modified low back pain disability questionnaire

volgende artikel Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures

Jason, L. A., Richman, J. A., Rademaker, A. W., Jordan, K. M., Plioplys, A. V., Taylor, R. R., McCready, W., Huang, C. F., & Plioplys, S. (1999). A community-based study of chronic fatigue syndrome. Archives of Internal Medicine, 159(18), 2129–2137.CrossRef

Reeves, W. C., Jones, J. F., Maloney, E., Heim, C., Hoaglin, D. C., Boneva, R. S., Morrissey, M., & Devlin, R. (2007). Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Population Health Metrics, 5, 5. https://doi.org/10.1186/1478-7954-5-5CrossRefPubMedPubMedCentral

Rowe, P. C., Underhill, R. A., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M. S., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: A primer. Frontiers in Pediatrics, 5, 121. https://doi.org/10.3389/fped.2017.00121CrossRefPubMedPubMedCentral

Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C. T., Arcos-Burgos, M., & Lidbury, B. A. (2019). Myalgic encephalomyelitis/chronic fatigue syndrome: A comprehensive review. Diagnostics (Basel), 9(3), 91. https://doi.org/10.3390/diagnostics9030091CrossRef

Lin, J.-M.S., Brimmer, D. J., Boneva, R. S., Jones, J. F., & Reeves, W. C. (2009). Barriers to healthcare utilization in fatiguing illness: A population-based study in Georgia. BMC Health Services Research, 9(1), 13. https://doi.org/10.1186/1472-6963-9-13CrossRefPubMedPubMedCentral

Unger, E. R., Lin, J.-M. S., Tian, H., Natelson, B. H., Lange, G., Vu, D., Blate, M., Klimas, N. G., Balbin, E. G., Bateman, L., Allen, A., Lapp, C. W., Springs, W., Kogelnik, A. M., Phan, C. C., Danver, J., Podell, R. N., Fitzpatrick, T., Peterson, D. L., … Rajeevan, M. S. (2017). Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): Design and implementation of a prospective/retrospective rolling cohort study. American Journal of Epidemiology, 185(8), 617–626. https://doi.org/10.1093/aje/kwx029

Pendergrast, T., Brown, A., Sunnquist, M., Jantke, R., Newton, J. L., Strand, E. B., & Jason, L. A. (2016). Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illness, 12(4), 292–307. https://doi.org/10.1177/1742395316644770CrossRefPubMedPubMedCentral

Conroy, K., Bhatia, S., Islam, M., & Jason, L. A. (2021). Homebound versus bedridden status among those with myalgic encephalomyelitis/chronic fatigue syndrome. Healthcare (Basel), 9(2), 106. https://doi.org/10.3390/healthcare9020106CrossRef

Reynolds, K. J., Vernon, S. D., Bouchery, E., & Reeves, W. C. (2004). The economic impact of chronic fatigue syndrome. Cost Effectiveness and Resource Allocation, 2(1), 4. https://doi.org/10.1186/1478-7547-2-4CrossRefPubMedPubMedCentral

10.

Jason, L. A., Benton, M. C., Valentine, L., Johnson, A., & Torres-Harding, S. (2008). The economic impact of ME/CFS: Individual and societal costs. Dynamic Medicine, 7, 6. https://doi.org/10.1186/1476-5918-7-6CrossRefPubMedPubMedCentral

11.

Lin, J. S., Resch, S. C., Brimmer, D. J., Johnson, A., Kennedy, S., Burstein, N., & Simon, C. J. (2011). The economic impact of chronic fatigue syndrome in Georgia: Direct and indirect costs. Cost Effectiveness and Resource Allocation, 9(1), 1. https://doi.org/10.1186/1478-7547-9-1CrossRefPubMedPubMedCentral

12.

Clayton, E. W. (2015). Beyond myalgic encephalomyelitis/chronic fatigue syndrome: An IOM report on redefining an illness. JAMA, 313(11), 1101–1102. https://doi.org/10.1001/jama.2015.1346CrossRefPubMed

13.

The Centers for Disease Control and Prevention. (2022, March 14). Myalgic encephalomyelitis/chronic fatigue syndrome. Retrieved from https://www.cdc.gov/me-cfs/

14.

Chang, C.-J., Hung, L.-Y., Kogelnik, A. M., Kaufman, D., Aiyar, R. S., Chu, A. M., Wilhelmy, J., Li, P., Tannenbaum, L., Xiao, W., & Davis, R. W. (2021). A Comprehensive examination of severely ill ME/CFS patients. Healthcare, 9(10), 1290.CrossRef

15.

Friedman, K. J., Murovska, M., Pheby, D. F. H., & Zalewski, P. (2021). Our evolving understanding of ME/CFS. Medicina (Kaunas, Lithuania), 57(3), 200. https://doi.org/10.3390/medicina57030200CrossRef

16.

Wong, T. L., & Weitzer, D. J. (2021). Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—A systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas, Lithuania), 57(5), 418. https://doi.org/10.3390/medicina57050418CrossRef

17.

The Centers for Disease Control and Prevention. Post-COVID Conditions. Retrieved April 21, 2022 from https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html

18.

Wanga, V., et al. (2021). Long-term symptoms among adults tested for SARS-CoV-2—United States, January 2020–April 2021. Morbidity and Mortality Weekly Report (MMWR), 70(36), 1235–1241. https://doi.org/10.15585/mmwr.mm7036a1CrossRef

19.

Yang, M., Keller, S., & Lin, J.-M.S. (2019). Psychometric properties of the PROMIS® Fatigue Short Form 7a among adults with myalgic encephalomyelitis/chronic fatigue syndrome. Quality of Life Research, 28(12), 3375–3384.CrossRef

20.

Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., & Komaroff, A. (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine, 121(12), 953–959.CrossRef

21.

Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., & Powles, A. P. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome, 11(1), 7–115.CrossRef

22.

Carruthers, B. M., van de Sande, M. I., De Meirleir, K. L., Klimas, N. G., Broderick, G., Mitchell, T., Staines, D., Powles, A. C. P., Speight, N., Vallings, R., Bateman, L., Baumgarten-Austrheim, B., Bell, D. S., Carlo-Stella, N., Chia, J., Darragh, A., Jo, D., Lewis, D., Light, A. R., … Stevens, S. (2011). Myalgic encephalomyelitis: International consensus criteria. Journal of Internal Medicine, 270(4), 327–338. https://doi.org/10.1111/j.1365-2796.2011.02428.x

23.

Lim, E. J., & Son, C. G. (2020). Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine, 18(1), 289. https://doi.org/10.1186/s12967-020-02455-0CrossRefPubMedPubMedCentral

24.

Jackson, M. L., & Bruck, D. (2012). Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: A review. Journal of Clinical Sleep Medicine, 8(6), 719–728. https://doi.org/10.5664/jcsm.2276CrossRefPubMedPubMedCentral

25.

Mariman, A. N., Vogelaers, D. P., Tobback, E., Delesie, L. M., Hanoulle, I. P., & Pevernagie, D. A. (2013). Sleep in the chronic fatigue syndrome. Sleep Medicine Reviews, 17(3), 193–199. https://doi.org/10.1016/j.smrv.2012.06.003CrossRefPubMed

26.

Nisenbaum, R., Jones, J. F., Unger, E. R., Reyes, M., & Reeves, W. C. (2003). A population-based study of the clinical course of chronic fatigue syndrome. Health and Quality of Life Outcomes, 1, 49–49. https://doi.org/10.1186/1477-7525-1-49CrossRefPubMedPubMedCentral

27.

Nisenbaum, R., Reyes, M., Unger, E. R., & Reeves, W. C. (2004). Factor analysis of symptoms among subjects with unexplained chronic fatigue: What can we learn about chronic fatigue syndrome? Journal of Psychosomatic Research, 56(2), 171–178. https://doi.org/10.1016/s0022-3999(03)00039-4CrossRefPubMed

28.

Hamaguchi, M., Kawahito, Y., Takeda, N., Kato, T., & Kojima, T. (2011). Characteristics of chronic fatigue syndrome in a Japanese community population: Chronic fatigue syndrome in Japan. Clinical Rheumatology, 30(7), 895–906. https://doi.org/10.1007/s10067-011-1702-9CrossRefPubMed

29.

Watson, N. F., Kapur, V., Arguelles, L. M., Goldberg, J., Schmidt, D. F., Armitage, R., & Buchwald, D. (2003). Comparison of subjective and objective measures of insomnia in monozygotic twins discordant for chronic fatigue syndrome. Sleep, 26(3), 324–328. https://doi.org/10.1093/sleep/26.3.324CrossRefPubMed

30.

Unger, E. R., Nisenbaum, R., Moldofsky, H., Cesta, A., Sammut, C., Reyes, M., & Reeves, W. C. (2004). Sleep assessment in a population-based study of chronic fatigue syndrome. BMC Neurology, 4, 6–6. https://doi.org/10.1186/1471-2377-4-6CrossRefPubMedPubMedCentral

31.

Creti, L., Libman, E., Baltzan, M., Rizzo, D., Bailes, S., & Fichten, C. S. (2010). Impaired sleep in chronic fatigue syndrome: How is it best measured? Journal of Health Psychology, 15(4), 596–607. https://doi.org/10.1177/1359105309355336CrossRefPubMed

32.

Maksoud, R., Eaton-Fitch, N., Matula, M., Cabanas, H., Staines, D., & Marshall-Gradisnik, S. (2021). Systematic review of sleep characteristics in myalgic encephalomyelitis/chronic fatigue syndrome. Healthcare (Basel), 9(5), 568. https://doi.org/10.3390/healthcare9050568CrossRef

33.

Watson, N. F., Jacobsen, C., Goldberg, J., Kapur, V., & Buchwald, D. (2004). Subjective and objective sleepiness in monozygotic twins discordant for chronic fatigue syndrome. Sleep, 27(5), 973–977. https://doi.org/10.1093/sleep/27.5.973CrossRefPubMed

34.

Reeves, W. C., Heim, C., Maloney, E. M., Youngblood, L. S., Unger, E. R., Decker, M. J., Jones, J. F., & Rye, D. B. (2006). Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: Results from a population-based study. BMC Neurology, 6, 41. https://doi.org/10.1186/1471-2377-6-41CrossRefPubMedPubMedCentral

35.

Majer, M., Jones, J. F., Unger, E. R., Youngblood, L. S., Decker, M. J., Gurbaxani, B., Heim, C., & Reeves, W. C. (2007). Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: Results from a population-based study. BMC Neurology, 7, 40. https://doi.org/10.1186/1471-2377-7-40CrossRefPubMedPubMedCentral

36.

Aaron, L. A., Burke, M. M., & Buchwald, D. (2000). Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Archives of Internal Medicine, 160(2), 221–227. https://doi.org/10.1001/archinte.160.2.221CrossRefPubMed

37.

McGregor, N. R., Armstrong, C. W., Lewis, D. P., Butt, H. L., & Gooley, P. R. (2016). Widespread pain and altered renal function in ME/CFS patients. Fatigue: Biomedicine, Health & Behavior, 4(3), 132–145. https://doi.org/10.1080/21641846.2016.1207400CrossRef

38.

Meeus, M., Nijs, J., & Meirleir, K. D. (2007). Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: A systematic review. European Journal of Pain, 11(4), 377–386. https://doi.org/10.1016/j.ejpain.2006.06.005CrossRefPubMed

39.

Food and Drug Administration. (2013). The voice of the patient: Chronic fatigue syndrome and myalgic encephalomyelitis. Center for Drug Evaluation and Research (CDER), Food and Drug Administration.

40.

Unger, E. (2013). Measures of CFS in a multi-site clinical study. FDA Scientific Drug Development Workshop.

41.

Aaron, L. A., Arguelles, L. M., Ashton, S., Belcourt, M., Herrell, R., Goldberg, J., Smith, W. R., & Buchwald, D. (2002). Health and functional status of twins with chronic regional and widespread pain. Journal of Rheumatology, 29(11), 2426–2434.PubMed

42.

Strand, E. B., Castro-Marrero, J., Helland, I., Alegre, J., & Mengshoel, A. M. (2020). Pain and depression are associated with more anxiety in ME/CFS: A cross-sectional cohort study between Norway and Spain. Clinical Medicine Insights: Psychiatry, 11, 1–8. https://doi.org/10.1177/1179557320941478CrossRef

43.

Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The fibromyalgia impact questionnaire: Development and validation. Journal of Rheumatology, 18(5), 728–733.PubMed

44.

Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009). The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. Arthritis Research & Therapy, 11(4), R120. https://doi.org/10.1186/ar2783CrossRef

45.

Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994). Pain and its treatment in outpatients with metastatic cancer. New England Journal of Medicine, 330(9), 592–596. https://doi.org/10.1056/nejm199403033300902CrossRefPubMed

46.

Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.CrossRef

47.

Jason, L. A., Evans, M., Porter, N., Brown, M., Brown, A., Hunnell, J., Anderson, V., Lerch, A., Meirleir, K. D., & Friedberg, F. (2010). The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. American Journal of Biochemistry and Biotechnology, 6(2), 120–135. https://doi.org/10.3844/ajbbsp.2010.120.135CrossRef

48.

Wagner, D., Nisenbaum, R., Heim, C., Jones, J. F., Unger, E. R., & Reeves, W. C. (2005). Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Population Health Metrics, 3, 8. https://doi.org/10.1186/1478-7954-3-8CrossRefPubMedPubMedCentral

49.

Jason, L. A., Ropacki, M. T., Santoro, N. B., Richman, J. A., Heatherly, W., Taylor, R., Ferrari, J. R., Haney-Davis, T. M., Rademaker, A., Dupuis, J., Golding, J., Plioplys, A. V., & Plioplys, S. (1997). A screening instrument for chronic fatigue syndrome: Reliability and validity. Journal of Chronic Fatigue Syndrome, 3(1), 39–59. https://doi.org/10.1300/J092v03n01_04CrossRef

50.

Bjorner, J. B., Rose, M., Gandek, B., Stone, A. A., Junghaenel, D. U., & Ware, J. E., Jr. (2014). Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity. Journal of Clinical Epidemiology, 67(1), 108–113. https://doi.org/10.1016/j.jclinepi.2013.07.016CrossRefPubMedPubMedCentral

51.

Embretson, S. E., & Reise, S. P. (2013). Item response theory. Psychology Press.CrossRef

52.

Liu, H., Cella, D., Gershon, R., Shen, J., Morales, L. S., Riley, W., & Hays, R. D. (2010). Representativeness of the PROMIS internet panel. Journal of Clinical Epidemiology, 63(11), 1169–1178. https://doi.org/10.1016/j.jclinepi.2009.11.021CrossRefPubMedPubMedCentral

53.

Yu, L., Buysse, D. J., Germain, A., Moul, D. E., Stover, A., Dodds, N. E., Johnston, K. L., & Pilkonis, P. A. (2011). Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behavioral Sleep Medicine, 10(1), 6–24. https://doi.org/10.1080/15402002.2012.636266CrossRefPubMedPubMedCentral

54.

Amtmann, D., Cook, K. F., Jensen, M. P., Chen, W. H., Choi, S., Revicki, D., Cella, D., Rothrock, N., Keefe, F., Callahan, L., & Lai, J. S. (2010). Development of a PROMIS item bank to measure pain interference. Pain, 150(1), 173–182. https://doi.org/10.1016/j.pain.2010.04.025CrossRefPubMedPubMedCentral

55.

Revicki, D. A., Chen, W.-H., Harnam, N., Cook, K. F., Amtmann, D., Callahan, L. F., Jensen, M. P., & Keefe, F. J. (2009). Development and psychometric analysis of the PROMIS pain behavior item bank. Pain, 146(1), 158–169. https://doi.org/10.1016/j.pain.2009.07.029CrossRefPubMedPubMedCentral

56.

SAS Institute Inc. (2002–2014). SAS® 9.4 help and documentation. SAS Institute Inc.

57.

Muthén, L. K., & Muthén, B. O. (1998–2017). Mplus user’s guide. Eighth Edition. Muthén and Muthén.

58.

Cai, L., Thissen, D., & du Toit, S. H. C. (2011). IRTPRO: Flexible, multidimensional, multiple categorical IRT modeling. Scientific Software International.

59.

Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRef

60.

Wang, L., Zhang, Z., McArdle, J. J., & Salthouse, T. A. (2009). Investigating ceiling effects in longitudinal data analysis. Multivariate Behavioral Research, 43(3), 476–496. https://doi.org/10.1080/00273170802285941CrossRefPubMedPubMedCentral

61.

McDonald, R. P. (1999). Test theory: A unified treatment. Erlbaum.

62.

Reise, S. P., Morizot, J., & Hays, R. D. (2007). The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Quality of Life Research, 16(1), 19–31.CrossRef

63.

Rodriguez, A., Reise, S. P., & Haviland, M. G. (2016). Evaluating bifactor models: Calculating and interpreting statistical indices. Psychological Methods, 21(2), 137–150.CrossRef

64.

Hu, L.-T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1–55. https://doi.org/10.1080/10705519909540118CrossRef

65.

Samejima, F. (1997). Graded response model. Handbook of modern item response theory (pp. 85–100). Springer.CrossRef

66.

Green, S. B., & Yang, Y. (2009). Reliability of summed item scores using structural equation modeling: An alternative to coefficient alpha. Psychometrika, 74(1), 155–167. https://doi.org/10.1007/s11336-008-9099-3CrossRef

67.

Yang, Y., & Xia, Y. (2019). Categorical omega with small sample sizes via Bayesian estimation: An alternative to frequentist estimators. Educational and Psychological Measurement, 79(1), 19–39. https://doi.org/10.1177/0013164417752008CrossRefPubMed

68.

Bentler, P. M. (2009). Alpha, dimension-free, and model-based internal consistency reliability. Psychometrika, 74(1), 137–143.CrossRef

69.

Dunn, T. J., Baguley, T., & Brunsden, V. (2014). From alpha to omega: A practical solution to the pervasive problem of internal consistency estimation. British Journal of Psychology, 105(3), 399–412.CrossRef

70.

Peters, G.-J. (2014). The alpha and the omega of scale reliability and validity: Why and how to abandon Cronbach’s alpha and the route towards more comprehensive assessment of scale quality. European Health Psychologist, 16(2), 56–69. https://doi.org/10.31234/osf.io/h47fvCrossRef

71.

Nunnally, J. C. (1978). Psychometric theory. McGraw-Hill.

72.

Lohr, K. N. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205.CrossRef

73.

Bartlett, S. J., Orbai, A. M., Duncan, T., DeLeon, E., Ruffing, V., Clegg-Smith, K., & Bingham, C. O., III. (2015). Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. PLoS ONE, 10(9), e0138543. https://doi.org/10.1371/journal.pone.0138543CrossRefPubMedPubMedCentral

74.

Quach, C. W., Langer, M. M., Chen, R. C., Thissen, D., Usinger, D. S., Emerson, M. A., & Reeve, B. B. (2016). Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study. Quality of Life Research, 25(11), 2811–2823. https://doi.org/10.1007/s11136-016-1325-3CrossRefPubMedPubMedCentral

75.

Merriwether, E. N., Rakel, B. A., Zimmerman, M. B., Dailey, D. L., Vance, C. G. T., Darghosian, L., Golchha, M., Geasland, K. M., Chimenti, R., Crofford, L. J., & Sluka, K. A. (2017). Reliability and construct validity of the patient-reported outcomes measurement information system (PROMIS) instruments in women with fibromyalgia. Pain Medicine (Malden, Mass.), 18(8), 1485–1495. https://doi.org/10.1093/pm/pnw187CrossRef

76.

Full, K. M., Malhotra, A., Crist, K., Moran, K., & Kerr, J. (2019). Assessing psychometric properties of the PROMIS Sleep Disturbance Scale in older adults in independent-living and continuing care retirement communities. Sleep Health, 5(1), 18–22. https://doi.org/10.1016/j.sleh.2018.09.003CrossRefPubMed

77.

Chimenti, R. L., Rakel, B. A., Dailey, D. L., Vance, C. G. T., Zimmerman, M. B., Geasland, K. M., Williams, J. M., Crofford, L. J., & Sluka, K. A. (2021). Test-retest reliability and responsiveness of PROMIS sleep short forms within an RCT in women with fibromyalgia. Frontiers in Pain Research, 2, 682072. https://doi.org/10.3389/fpain.2021.682072CrossRefPubMedPubMedCentral

78.

Lord, F. M. (1980). Applications of item response theory to practical testing problems. Routledge.

79.

Langer, M. M. (2008). A reexamination of Lord’s Wald test for differential item functioning using item response theory and modern error estimation [Doctoral Dissertation, University of North Carolina at Chapel Hill]. Retrieved from https://cdr.lib.unc.edu/record/uuid:3ef47e17-9b76-45be-bf49-febddc17f4e0

80.

Reyes, M., Nisenbaum, R., Hoaglin, D. C., Unger, E. R., Emmons, C., Randall, B., Stewart, J. A., Abbey, S., Jones, J. F., Gantz, N., & Minden, S. (2003). Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Archives of Internal Medicine, 163(13), 1530–1536. https://doi.org/10.1001/archinte.163.13.1530CrossRefPubMed

81.

Rusu, C., Gee, M. E., Lagacé, C., & Parlor, M. (2015). Chronic fatigue syndrome and fibromyalgia in Canada: Prevalence and associations with six health status indicators. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice, 35(1), 3–11.CrossRef

82.

Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological), 57(1), 289–300.CrossRef

83.

Thissen, D., Steinberg, L., & Kuang, D. (2002). Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. Journal of Educational and Behavioral Statistics, 27(1), 77–83. https://doi.org/10.3102/10769986027001077CrossRef

84.

National Institute of Neurological Disorders and Stroke. (2022, March 14). Common data elements for myalgic encephalomyelitis/chronic fatigue syndrome. Retrieved from https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome

85.

Tukey, J. W. (1949). Comparing individual means in the analysis of variance. Biometrics, 5(2), 99–114. https://doi.org/10.2307/3001913CrossRefPubMed

86.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Routledge.

87.

Miles, J., & Shevlin, M. (2001). Applying regression & correlation: A guide for students and researchers (1st ed.). Sage Publications.

88.

Badhiwala, J. H., Witiw, C. D., Nassiri, F., Akbar, M. A., Jaja, B., Wilson, J. R., & Fehlings, M. G. (2018). Minimum clinically important difference in SF-36 scores for use in degenerative cervical myelopathy. Spine. https://doi.org/10.1097/brs.0000000000002684CrossRefPubMed

89.

Swigris, J. J., Brown, K. K., Behr, J., du Bois, R. M., King, T. E., Raghu, G., & Wamboldt, F. S. (2010). The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF. Respiratory medicine, 104(2), 296–304. https://doi.org/10.1016/j.rmed.2009.09.006CrossRefPubMed

90.

Ward, M. M., Guthrie, L. C., & Alba, M. I. (2014). Clinically important chances in short form-36 scales for use in rheumatoid arthritis clinical trials: The impact of low responsiveness. Arthritis Care & Research, 66(12), 1783–1789. https://doi.org/10.1002/acr.22392CrossRef

91.

Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The Remarkable Universality of half a standard deviation. Medical Care, 41(5), 582–592. https://doi.org/10.1097/01.mlr.0000062554.74615.4cCrossRefPubMed

92.

Guyatt, G., Walter, S., & Norman, G. (1987). Measuring change over time: Assessing the usefulness of evaluative instruments. Journal of Chronic Diseases, 40(2), 171–178. https://doi.org/10.1016/0021-9681(87)90069-5CrossRefPubMed

93.

Cook, K. F., Kallen, M. A., & Amtmann, D. (2009). Having a fit: Impact of number of items and distribution of data on traditional criteria for assessing IRT’s unidimensionality assumption. Quality of Life Research, 18(4), 447–460. https://doi.org/10.1007/s11136-009-9464-4CrossRefPubMedPubMedCentral

94.

Hildenbrand, A. K., Quinn, C. T., Mara, C. A., Peugh, J. L., McTate, E. A., Britto, M. T., & Crosby, L. E. (2019). A preliminary investigation of the psychometric properties of PROMIS® scales in emerging adults with sickle cell disease. Health Psychology, 38(5), 386–390. https://doi.org/10.1037/hea0000696CrossRefPubMedPubMedCentral

95.

Becker, B., Raymond, K., Hawkes, C., Foster, A. M., Lovley, A., Saucier, C., Rizio, A. A., Bjorner, J. B., & Kosinski, M. (2021). Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis. Journal of Patient-Reported Outcomes, 5(1), 52. https://doi.org/10.1186/s41687-021-00318-wCrossRefPubMedPubMedCentral

96.

Yost, K. J., Eton, D. T., Garcia, S. F., & Cella, D. (2011). Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. Journal of Clinical Epidemiology, 64(5), 507–516. https://doi.org/10.1016/j.jclinepi.2010.11.018CrossRefPubMedPubMedCentral

97.

Chen, C. X., Kroenke, K., Stump, T. E., Kean, J., Carpenter, J. S., Krebs, E. E., Bair, M. J., Damush, T. M., & Monahan, P. O. (2018). Estimating minimally important differences for the PROMIS pain interference scales: Results from 3 randomized clinical trials. Pain, 159(4), 775–782. https://doi.org/10.1097/j.pain.0000000000001121CrossRefPubMedPubMedCentral

98.

Purvis, T. E., Neuman, B. J., Riley, L. H., 3rd., & Skolasky, R. L. (2018). Discriminant ability, concurrent validity, and responsiveness of PROMIS health domains among patients with lumbar degenerative disease undergoing decompression with or without arthrodesis. Spine, 43(21), 1512–1520. https://doi.org/10.1097/brs.0000000000002661CrossRefPubMed

99.

Katz, P., Pedro, S., Alemao, E., Yazdany, J., Dall’Era, M., Trupin, L., Rush, S., & Michaud, K. (2020). Estimates of responsiveness, minimally important differences, and patient acceptable symptom state in five patient-reported outcomes measurement information system short forms in systemic lupus erythematosus. ACR Open Rheumatology, 2(1), 53–60. https://doi.org/10.1002/acr2.11100CrossRefPubMed

Titel: Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS® sleep and pain short forms
Auteurs: Manshu Yang
San Keller
Jin-Mann S. Lin
Publicatiedatum: 27-07-2022
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 12/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-022-03199-8

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 12/2022

Health-related quality of life in long-term Caribbean prostate cancer survivors: comparisons with prostate cancer-free men

The role of parental health and distress in assessing children’s health status

Measurement properties of the Dutch PROMIS-29 v2.1 profile in people with and without chronic conditions

Publisher Correction to: Response to the discussion of the assessment of functioning

The patient-reported outcomes measurement information systems (PROMIS®) physical function and its derivative measures in adults: a systematic review of content validity

Health-related quality of life analysis in ovarian cancer clinical trials involving PARP inhibitors: a critical methodological perspective